Diabetes and Obesity

Do you have type 2 diabetes? Are you taking Metformin only and your diabetes is still not under control?

This is a 26 week, Double blind, placebo controlled Phase 2 study, assessing the safety and efficacy of an investigational medication in patients with Type 2 Diabetes. You may qualify for this Type 2 Diabetes study if:

  • You are between 18 and 80 years of age
  • Been diagnosed with Type 2 Diabetes
  • For the past 3 months, you have been primarily treating your diabetes with diet and exercise and/or Metformin

There are no study related costs and reimbursement will be provided to patients who qualify.

Type 2 Diabetes - Explore a New Opportunity!

This SOTA study is evaluating an investigational oral tablet compared to placebo that may help manage one’s blood glucose level.

Participants will be required to attend regular office visits throughout the duration of the study. The subject will be given glucose monitoring supplies and asked to record their blood glucose level in a diary.

To be eligible for the study, you must:
1) Be diagnosed with Type 2 Diabetes
2) Are 18 years of age or older
3) Have A1C level 7-10%
4) Are taking a sulfonylurea medication for T2D, such as chlorpropamide, glimepiride, glyburide, glipizide, tolazamide, or tolbutamide with or without Metformin

Qualified participants will receive:
1) Investigational oral tablet or a placebo
2) Medical Assessments and laboratory tests at no cost
3) Compensation for time and travel

Do you have Type 2 Diabetes and being treated with basal insulin such as Lantus, Levemir or NPH Insulin?

This is a 52 week trial comparing the efficacy and safety of two types of insulin in subjects with type 2 diabetes, inadequately treated with basal insulin with or without oral antidiabetic drugs.

You may qualify if you:

  • Are 18 years of age or older
  • Diagnosed with type 2 diabetes
  • Treated with basal insulin for at least 90 days with or without certain oral anti-diabetic medications

Benefits of participating includes:

  • Comprehensive care including regular health and medical testing
  • Access to trial medication and blood glucose testing equipment
  • May be compensated for time and travel

Do you have Type 2 Diabetes?

The purpose of the SUSTAIN 8 clinical trial is to compare the safety and efficacy of two trial products in patients who have only received Metformin as a treatment for their Type 2 Diabetes.

To join the trial, you must:

1) Be 18 years or above
2) Have type 2 diabetes
3) Have been treated with Metformin for at least 90 days
4) Be able to attend 9 clinic visits and answer 2 phone contacts throughout the 59 weeks trial period

Subjects will receive:

1) Comprehensive care including regular health checks and medical testing
2) Access to trial medication and blood glucose testing at no cost
3) Compensation for time and travel